Psychiatry and Neurology, Neurology with Special Qualifications in Child Neurology · Baltimore, MD
NPI
1386866564
Since 2007
Specialty
Psychiatry and Neurology, Neurology with Special Qualifications in Child Neurology
Code 2084N0402X
Group practices
2
Medicare group memberships
Hospitals
1
Hospital affiliations
200 N Wolfe St, Suite 2147
Baltimore, MD, 21287
Phone (410) 955-7212
Groups this clinician bills Medicare through
Medicare paid
-
No Medicare services published
Medicare patients
-
Drug cost, 2024
$3.5M
90 prescriptions
Company payments, 2025
$3,867
From 2 companies
Medicare prescription drug claims, 2024
In 2024, the drug Constance Smith-Hicks prescribed most often to Medicare patients was Daybue (Trofinetide), with 52 prescriptions and refills. In total Constance Smith-Hicks wrote 90 Medicare prescriptions that cost $3.5M.
| Drug |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2024-11-25.
| Claims |
|---|
| 30-day fills |
|---|
| Patients |
|---|
| Cost |
|---|
| Daybue Trofinetide | 52 | 52 | Under 11 | $3.5M |
| Fluoxetine Hcl Generic | 12 | 12 | Under 11 | $174 |
| Levetiracetam Generic | 11 | 11 | Under 11 | $411 |
Brand drugs: 53 claims; generic drugs: 37 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Constance Smith-Hicks $3,867 ($3,867 in general payments such as food, travel and fees) from 2 companies. The largest payer was ACADIA Pharmaceuticals Inc with $2,411.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.